Medicine and Dentistry
Hepatocellular Carcinoma
100%
Sorafenib
75%
Nonalcoholic Fatty Liver
62%
Combination Therapy
25%
Clinical Feature
25%
Liver Cirrhosis
25%
Chronic Liver Disease
25%
Patient
25%
Placebo
25%
Diseases
12%
Insulin Resistance
12%
Obesity
12%
Fibrosis
12%
Mediator
12%
Cohort Effect
12%
Tumor Progression
12%
Serositis
12%
Malignant Neoplasm
12%
Triacylglycerol
12%
Liver Disease
12%
Tyrosine
12%
Antiinfective Agent
12%
Overall Survival
12%
Liver Injury
12%
Liver Cell Damage
12%
Protein Serine Threonine Kinase
12%
Steatosis
12%
Autophagy
12%
Thinking
12%
Hepatic Stellate Cell
12%
Enalapril Maleate
12%
Epidemiology
12%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Sorafenib
75%
Nonalcoholic Fatty Liver
62%
Clinical Feature
25%
Epidemiology
25%
Liver Cirrhosis
25%
Chronic Liver Disease
25%
Diseases
12%
Liver Disease
12%
Antiinfective Agent
12%
Fibrosis
12%
Malignant Neoplasm
12%
Triacylglycerol
12%
Liver Injury
12%
Tumor Growth
12%
Overall Survival
12%
Steatosis
12%
Obesity
12%
Insulin Resistance
12%
Tyrosine
12%
Death
12%
Enalapril Maleate
12%
Syndrome
12%
Liver Cell Damage
12%
Protein Serine Threonine Kinase
12%